---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-249830"
form_type: "8-K"
ticker: null
cik: "0001597553"
company_name: "Sage Therapeutics, Inc."
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T06:56:51.146574+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sage Therapeutics CFO and GC depart as part of workforce reorganization; separation agreements signed

## Summary
- CFO Kimi Iguchi and GC Anne Marie Cook resigned on Oct 31, 2024, as part of a previously announced workforce reorganization.
- Iguchi receives 12-month salary continuation, COBRA, and a prorated 50% bonus; also enters consulting agreement through Mar 31, 2025, with hourly pay.
- Cook receives similar severance (12-month salary continuation, COBRA, prorated 50% bonus); no consulting agreement.
- Equity awards amended: for Iguchi, vesting continues during consulting and exercise extended to Oct 31, 2025; for Cook, exercise extended to same date.

## SEC filing metadata
- accession: 0001193125-24-249830
- form_type: 8-K
- cik: 0001597553
- company_name: Sage Therapeutics, Inc.
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1597553/000119312524249830/0001193125-24-249830-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1597553/000119312524249830/d843349d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-249830
- JSON: https://secwatch.observer/filing/0001193125-24-249830.json
- Plain text: https://secwatch.observer/filing/0001193125-24-249830.txt

## Key facts
- Executive change
  Anne Marie Cook resigned as Senior Vice President, General Counsel and Secretary at Sage Therapeutics, Inc..
  - Action: resigned
  - Role: Senior Vice President, General Counsel and Secretary
  source text: On the Separation Date, Anne Marie Cook and the Company entered into a separation agreement (the “Cook Separation Agreement”) providing for the resignation of Ms. Cook from her positions as Senior Vice President, General Counsel and Secretary of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1597553/000119312524249830/0001193125-24-249830-index.htm
- Executive change
  Kimi Iguchi resigned as Chief Financial Officer and Treasurer at Sage Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer and Treasurer
  source text: On October 31, 2024 (the “Separation Date”), Kimi Iguchi and Sage Therapeutics, Inc. (the “Company”) entered into a separation agreement (the “Iguchi Separation Agreement”) providing for the resignation of Ms. Iguchi from her positions as the Chief Financial Officer and Treasurer of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1597553/000119312524249830/0001193125-24-249830-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.